# VASO Corp (VASO)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/vaso-corp/ JSON: https://steadybase.io/company/vaso-corp.json Checked Nov 10, 2026. Latest filing read: Oct 29, 2026.

## Company

- Legal name: VASO Corp
- Ticker: VASO (OTC)
- SEC CIK: 0000839087
- Industry: Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Headquarters: Plainview, NY
- Fiscal year ends: December 31
- SEC filer category: Non-accelerated filer<br>Smaller reporting company
- Website: vasocorporation.com
- Next earnings date: Nov 14, 2026 (estimated from past 8-K timing)

## Key facts

- Revenue: $89.1M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 31, 2026). Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/0001213900-26-037664-index.html
- Operating income: -$2.9M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 31, 2026). Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/0001213900-26-037664-index.html
- Net income: $1.6M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 31, 2026). Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/0001213900-26-037664-index.html
- SG&A: $52.2M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 31, 2026). Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/0001213900-26-037664-index.html
- Employees: 282 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm
- Shares outstanding: 176,018,035 as of Aug 12, 2026 (10-Q filed Aug 14, 2026). Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026090009/0001213900-26-090009-index.html
- Auditor: Uhy LLP, Sterling Heights, Michigan, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm

## Business

Vaso Corporation (the “Company”) principally operates in three distinct business segments in the healthcare equipment and information technology industries. We manage and evaluate our operations, and report our financial results, through these three business segments.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $89.1M | -$2.9M | $1.6M | $52.2M |
| Dec 31, 2024 | $86.8M | $285,000 | $951,000 | $49.0M |
| Dec 31, 2023 | $81.0M | $4.2M | $4.8M | $45.1M |
| Dec 31, 2022 | $79.3M | $6.5M | $11.3M | $40.8M |
| Dec 31, 2021 | $75.6M | $2.8M | $6.1M | $38.6M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/vaso-corp.json

## Officers and directors

- Jun Ma, President, Chief Executive Officer and Director. Source: 10-K filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm
- Jun Ma, PhD, President, Chief Executive Officer. Source: 10-K filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm
- Jonathan P. Newton, Chief Financial Officer, Treasurer and Secretary. Source: 10-K filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm
- Jane Moen, President of VasoHealthcare, Chief Operating Officer. Source: 10-K filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm
- Peter C. Castle, President of VasoTechnology. Source: 10-K filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm
- Edgar Rios, Vice Chairman of the Board and Director. Source: 10-K filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm
- Behnam Movaseghi, Director. Source: 10-K filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm
- David Lieberman, Director. Source: 10-K filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm
- Leon Dembo, Director. Source: 10-K filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm

## Recent 8-K events

- Jul 31, 2026: Item 1.01, Entry into a material definitive agreement; Item 2.01, Completion of acquisition or disposition of assets; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026084076/ea0300077-8k_vaso.htm
- Jul 23, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026080991/ea0299047-8k_vaso.htm
- May 8, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026053854/ea0289903-8k_vaso.htm
- Feb 12, 2026: Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/839087/000121390026015515/ea0276822-8k_vaso.htm
- Dec 19, 2025: Item 5.07, Submission of matters to a vote of security holders; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/839087/000121390025123593/ea0270345-8k_vaso.htm
- Nov 20, 2025: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/839087/000121390025112966/ea0266535-8k_vaso.htm
- Jan 3, 2025: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/839087/000121390025000753/ea0226798-8k_vaso.htm
- Sep 19, 2024: Item 1.02, Termination of a material definitive agreement; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/839087/000121390024079992/ea0215034-8k_vaso.htm
- Sep 10, 2024: Item 5.07, Submission of matters to a vote of security holders; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/839087/000121390024077416/ea0214067-8k425_vaso.htm
- Aug 28, 2024: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/839087/000121390024073043/ea0212610-8k425_vaso.htm

## Latest filings

- 8-K filed Jul 31, 2026: https://www.sec.gov/Archives/edgar/data/839087/000121390026084076/ea0300077-8k_vaso.htm
- 10-K filed Mar 31, 2026: https://www.sec.gov/Archives/edgar/data/839087/000121390026037664/ea0281952-10k_vasocorp.htm
- 10-Q filed Aug 14, 2026: https://www.sec.gov/Archives/edgar/data/839087/000121390026090009/ea0301696-10q_vaso.htm
- DEF 14A filed Oct 29, 2026: https://www.sec.gov/Archives/edgar/data/839087/000121390026113710/ea0309090-def14a_vaso.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/